HK1034969A1 - Dihydroxyhexanoic acid derivatives. - Google Patents

Dihydroxyhexanoic acid derivatives.

Info

Publication number
HK1034969A1
HK1034969A1 HK01105717A HK01105717A HK1034969A1 HK 1034969 A1 HK1034969 A1 HK 1034969A1 HK 01105717 A HK01105717 A HK 01105717A HK 01105717 A HK01105717 A HK 01105717A HK 1034969 A1 HK1034969 A1 HK 1034969A1
Authority
HK
Hong Kong
Prior art keywords
acid derivatives
dihydroxyhexanoic acid
dihydroxyhexanoic
derivatives
acid
Prior art date
Application number
HK01105717A
Other languages
English (en)
Inventor
John Charles Kath
Matthew Frank Brown
Christopher Stanley Poss
Original Assignee
Pfizer Product Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Product Inc filed Critical Pfizer Product Inc
Publication of HK1034969A1 publication Critical patent/HK1034969A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
HK01105717A 1998-02-05 2001-08-15 Dihydroxyhexanoic acid derivatives. HK1034969A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7380198P 1998-02-05 1998-02-05
PCT/IB1999/000067 WO1999040061A2 (fr) 1998-02-05 1999-01-18 Nouveaux derives d'acide dihydroxyhexanoique

Publications (1)

Publication Number Publication Date
HK1034969A1 true HK1034969A1 (en) 2001-11-09

Family

ID=22115885

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01105717A HK1034969A1 (en) 1998-02-05 2001-08-15 Dihydroxyhexanoic acid derivatives.

Country Status (37)

Country Link
EP (1) EP1051405B1 (fr)
JP (1) JP3693916B2 (fr)
KR (1) KR100385529B1 (fr)
CN (1) CN1177834C (fr)
AP (1) AP992A (fr)
AR (1) AR016175A1 (fr)
AT (1) ATE337307T1 (fr)
AU (1) AU752407B2 (fr)
BG (1) BG104726A (fr)
BR (1) BR9907655A (fr)
CA (1) CA2320388C (fr)
DE (1) DE69932920T2 (fr)
DZ (1) DZ2717A1 (fr)
EA (1) EA003137B1 (fr)
ES (1) ES2268847T3 (fr)
GT (1) GT199900011A (fr)
HK (1) HK1034969A1 (fr)
HR (1) HRP20000529B1 (fr)
HU (1) HUP0100832A3 (fr)
IL (1) IL137330A0 (fr)
IS (1) IS5562A (fr)
MA (1) MA26603A1 (fr)
MY (1) MY133125A (fr)
NO (1) NO20003965D0 (fr)
NZ (1) NZ505724A (fr)
OA (1) OA11448A (fr)
PA (1) PA8467301A1 (fr)
PE (1) PE20000243A1 (fr)
PL (1) PL342817A1 (fr)
SK (1) SK11262000A3 (fr)
TN (1) TNSN99013A1 (fr)
TR (1) TR200002248T2 (fr)
TW (1) TW470744B (fr)
UA (1) UA57824C2 (fr)
WO (1) WO1999040061A2 (fr)
YU (1) YU47100A (fr)
ZA (1) ZA99873B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2360672A1 (fr) * 1999-01-29 2000-08-03 Wayne W. Hancock Methodes de prevention des rejets de greffes et des lesions par ischemie/reperfusion
WO2001014339A2 (fr) * 1999-08-20 2001-03-01 Dow Agrosciences Llc Amides aromatiques heterocycliques fongicides et leurs compositions, mode d'emploi et preparation
CZ20022542A3 (cs) * 2000-02-04 2003-08-13 Pfizer Products Inc. Heterocyklické amidové deriváty
EP1498417A1 (fr) * 2000-02-04 2005-01-19 Pfizer Products Inc. Amides hétérocycliques
US6740636B2 (en) * 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
US6746856B2 (en) 2000-08-09 2004-06-08 Pfizer Inc. Microbial conversion of bicyclic heteroaromatic compounds
WO2003000235A1 (fr) * 2001-06-22 2003-01-03 Pfizer Products Inc. Compositions pharmaceutiques de dispersions de medicaments et de polymeres neutres
WO2003000238A1 (fr) 2001-06-22 2003-01-03 Pfizer Products Inc. Compositions pharmaceutiques de produits d'adsorption de medicament amorphe
EP1269994A3 (fr) * 2001-06-22 2003-02-12 Pfizer Products Inc. Compositions Pharmaceutiques comprenant un médicament et un polymère permettant d'améliorer la concentration du médicament
DE10152351B4 (de) * 2001-10-18 2005-09-22 Schering Ag Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat
JP2005523262A (ja) 2002-02-01 2005-08-04 ファイザー・プロダクツ・インク 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物
AU2003223052A1 (en) * 2002-05-14 2003-11-11 Pfizer Products Inc. Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making
AU2003223050A1 (en) * 2002-05-14 2003-11-11 Pfizer Products Inc. Methods for manufacture of dihydro-furan-2-one derivatives
PT1530457E (pt) 2002-08-12 2009-11-06 Bend Res Inc Composições farmacêuticas de fármacos na forma semi-ordenada e de polímeros
CA2494776A1 (fr) * 2002-08-12 2004-02-19 Pfizer Products Inc. Formes cristallines d'acide quinoxaline-2-carboxylique ¬4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl|-amide
US20040087571A1 (en) * 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
US20040097554A1 (en) * 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
BRPI0413277A (pt) 2003-08-04 2006-10-10 Pfizer Prod Inc composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923864A (en) * 1987-12-15 1990-05-08 Pfizer Inc. Certain heterocyclic-hexanamides useful for treating hypertension
ATE220661T1 (de) * 1994-10-19 2002-08-15 Novartis Erfind Verwalt Gmbh Antivirale ether von aspartat-protease-substrat- isosteren
DE19708106A1 (de) * 1997-02-28 1998-09-03 Bosch Gmbh Robert Einrichtung und Verfahren zur Information über Verkehrsstörungen

Also Published As

Publication number Publication date
HUP0100832A3 (en) 2002-03-28
EA200000741A1 (ru) 2001-02-26
WO1999040061A2 (fr) 1999-08-12
CA2320388A1 (fr) 1999-08-12
ATE337307T1 (de) 2006-09-15
GT199900011A (es) 2000-07-20
HRP20000529B1 (en) 2004-12-31
UA57824C2 (uk) 2003-07-15
KR20010040684A (ko) 2001-05-15
TW470744B (en) 2002-01-01
WO1999040061A3 (fr) 1999-10-21
TNSN99013A1 (fr) 2005-11-10
EP1051405A2 (fr) 2000-11-15
IL137330A0 (en) 2001-07-24
JP2002502839A (ja) 2002-01-29
JP3693916B2 (ja) 2005-09-14
NO20003965L (fr) 2000-10-03
EA003137B1 (ru) 2003-02-27
NO20003965D0 (no) 2000-08-04
HUP0100832A2 (hu) 2002-02-28
CA2320388C (fr) 2005-05-03
AP9901457A0 (en) 1999-03-31
AU1778999A (en) 1999-08-23
BG104726A (en) 2001-04-30
HRP20000529A2 (en) 2001-08-31
MA26603A1 (fr) 2004-12-20
ZA99873B (en) 2000-08-04
PE20000243A1 (es) 2000-04-07
DE69932920T2 (de) 2007-02-08
CN1290255A (zh) 2001-04-04
DZ2717A1 (fr) 2003-09-01
PA8467301A1 (es) 2000-05-24
CN1177834C (zh) 2004-12-01
ES2268847T3 (es) 2007-03-16
DE69932920D1 (de) 2006-10-05
AR016175A1 (es) 2001-06-20
BR9907655A (pt) 2000-10-24
EP1051405B1 (fr) 2006-08-23
OA11448A (en) 2003-11-18
NZ505724A (en) 2003-02-28
MY133125A (en) 2007-10-31
KR100385529B1 (ko) 2003-05-27
AU752407B2 (en) 2002-09-19
IS5562A (is) 2000-07-14
AP992A (en) 2001-08-06
SK11262000A3 (sk) 2001-01-18
YU47100A (sh) 2002-11-15
TR200002248T2 (tr) 2000-12-21
PL342817A1 (en) 2001-07-02

Similar Documents

Publication Publication Date Title
ZA992629B (en) (4-arylsulfonylamino)-tetrahydropyran-4-caboxylic acid hydroxamides.
IL139470A0 (en) Oxyiminoalkanoic acid derivatives
ZA99254B (en) Benzosulfone derivatives.
EG24140A (en) New 3-aryl-2-hydroxypropionic acid derivative
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
ZA992630B (en) Bicyclic hydroxamic acid derivatives.
IL140358A0 (en) Aminomethylarboxylic acid derivatives
ZA987126B (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives.
ZA200007593B (en) Quinoline Derivatives.
ZA996185B (en) Sulfanylsilanes.
ZA200005136B (en) Dihydropyrimides.
PL334997A1 (en) Derivatives or arylosulphonyl-hydroxamic acid
ZA99567B (en) Aryl-acrylic acid esters.
ZA981602B (en) Novel hexanoic acid derivatives.
HU9801044D0 (en) Sulfonyl-amino-carboxylic acid derivatives
HUP0003881A3 (en) Amidocarboxylic acid derivatives
ZA200109595B (en) 13-methyl-erythromycin derivatives.
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
HK1034969A1 (en) Dihydroxyhexanoic acid derivatives.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA991550B (en) Cyclohexanediole derivatives.
AU1268400A (en) Isothiazolecarboxylic acid derivatives
ZA982436B (en) Thiazolimine derivatives.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090118